GlassScriptPhysician profile
Heidi L Wess
NPI 1316920655
$525.82
in general payments reported to CMS, 2019-2025
12 companies · $71.95 in 2025
The $71.95 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.28 · 2022: $85.05 · 2023: $218 · 2024: $107 · 2025: $71.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amylyx Pharmaceuticals, INC. | $166.25 | 2023 | Relyvrio |
| Xeris Pharmaceuticals, INC. | $88.02 | 2022-2024 | Gvoke Hypopen |
| Verona Pharma, INC. | $56.94 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $35.75 | 2023-2024 | |
| Amgen INC. | $34.48 | 2021-2024 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $34.08 | 2022 | |
| Abbvie INC. | $30.06 | 2021 | |
| Biogen, INC. | $19.98 | 2024 | |
| Sanofi-Aventis U.S. LLC | $18.25 | 2023 | |
| Molnlycke Health Care US, LLC | $15.01 | 2025 | Mepilex Border, Mepilex Border Sacrum, Mepilex |
| Dexcom, INC. | $14.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Wess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.